wise-owl's valuation - 13.5c

For anyone interested in the report:

http://www.cellmid.com.au/index.php?option=com_content&view=article&id=96

Don't think they valued the earnings from the latest acquisition.

"CELLMID LAUNCHES LIFESTYLE SUBSIDIARY

* Recent preclinical studies indicate that midkine may be useful in the treatment of various forms of hair loss (alopecia)

* Cellmid has established a wholly owned subsidiary, Advangen, to commercialise this opportunity and other lifestyle products

*Advangen is also the sole Australasian distributor for a range of ethical hair loss treatments from Japan

*Revenue from these market ready products is expected to support the midkine alopecia program"

Also look forward to more lucrative licensing deals in the near future.

IMO, s/h's will be well rewarded.